Circio invites to R&D and corporate update webcast on 26 February 2026

Summary by AI BETAClose X

Circio Holding ASA will host a live webcast on February 26, 2026, at 10:00 AM CET, where CEO Dr. Erik D Wiklund will provide a corporate update, including a summary of recently completed financing transactions and a business outlook for 2026. CTO Dr. Thomas B Hansen will present new in vivo results demonstrating further validation and strengthening of the circVec platform for gene therapy applications, showcasing strong performance in new gene therapy areas and enhanced protein expression capabilities.

Disclaimer*

UK 100

Latest directors dealings